Firefly Neuroscience (AIFF) Capital Expenditures Growth (1y) (2011 - 2026)
Powered by 
Analysis
Firefly Neuroscience (AIFF) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 16.28% |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | -70.67% |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -75.16% |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 8.71% |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | -32.00% |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | -78.21% |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 42.86% |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | 250.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 250.00% |
| Mar 31, 2026 | 728.57% |
| Sep 30, 2025 | 26.47% |
| Jun 30, 2025 | -81.25% |
| Dec 31, 2022 | 2,096.17% |
| Sep 30, 2022 | 505.04% |
| Jun 30, 2022 | 7.95% |
| Mar 31, 2022 | 155.27% |
| Dec 31, 2021 | 132.67% |
| Sep 30, 2021 | -32.68% |
| Dec 31, 2020 | 470.72% |
| Sep 30, 2020 | 3,543.49% |
| Dec 31, 2019 | -38.97% |
| Sep 30, 2019 | 16.62% |
| Jun 30, 2019 | 3,903.36% |
| Dec 31, 2018 | 101.90% |
| Dec 31, 2017 | -54.25% |
| Dec 31, 2016 | -75.53% |
| Sep 30, 2016 | 17.64% |
| Jun 30, 2016 | -62.24% |